ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 70 filers reported holding ALPINE IMMUNE SCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,182,244 | +265.8% | 190,589 | +228.4% | 0.01% | +500.0% |
| Q2 2023 | $596,528 | +277.5% | 58,028 | +164.7% | 0.00% | 0.0% |
| Q3 2022 | $158,000 | -7.1% | 21,924 | +9.5% | 0.00% | 0.0% |
| Q2 2022 | $170,000 | -60.3% | 20,030 | -58.0% | 0.00% | 0.0% |
| Q1 2022 | $428,000 | -61.2% | 47,708 | -40.1% | 0.00% | -50.0% |
| Q4 2021 | $1,104,000 | +164.1% | 79,682 | +103.2% | 0.00% | +100.0% |
| Q3 2021 | $418,000 | +175.0% | 39,218 | +131.9% | 0.00% | – |
| Q2 2021 | $152,000 | -86.6% | 16,914 | -84.2% | 0.00% | -100.0% |
| Q1 2021 | $1,138,000 | -39.1% | 107,381 | -27.7% | 0.00% | -40.0% |
| Q4 2020 | $1,870,000 | +161.5% | 148,443 | +82.4% | 0.01% | +66.7% |
| Q3 2020 | $715,000 | -5.9% | 81,365 | +3.9% | 0.00% | -25.0% |
| Q2 2020 | $760,000 | – | 78,299 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 2,571,450 | $32,400,000 | 2.50% |
| Omega Fund Management, LLC | 1,284,900 | $16,190,000 | 2.43% |
| Avidity Partners Management LP | 1,248,000 | $15,725,000 | 0.51% |
| Samsara BioCapital, LLC | 399,190 | $5,030,000 | 0.51% |
| EcoR1 Capital, LLC | 741,290 | $9,340,000 | 0.50% |
| DAFNA Capital Management LLC | 113,202 | $1,426,000 | 0.42% |
| TIGER MANAGEMENT L.L.C. | 137,728 | $1,735,000 | 0.39% |
| Orbimed Advisors | 3,070,955 | $38,694,000 | 0.34% |
| SPHERA FUNDS MANAGEMENT LTD. | 198,260 | $2,498,000 | 0.22% |
| Artal Group S.A. | 593,030 | $7,472,000 | 0.16% |